This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $561,584 to study the ovarian disrupting effects of per- and polyfluoroalkyl substances (PFAS) on female reproductive health. The research aims to investigate how exposure to the "forever chemical" PFNA, as well as PFAS mixtures, can interfere with ovarian follicle maturation and ovulation. The study will integrate in...
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
This $322,328 Project Grant was awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) federal grant program. The grant will support research to (1) assess the prevalence, predictors, and potential exposure sources of per- and polyfluoroalkyl substances (PFAS) among U.S. volunteer firefighters, and (2) examine associations between PFAS levels and dyslipidemia (blood lipid imbalances) in this population. The project leverages data...
The University of Illinois was awarded a $798,912 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate how PFAS (per- and polyfluoroalkyl substances) exposures can reprogram prostate stem cells and drive carcinogenesis and cancer progression. The 3-year project, running from July 1, 2023 to June 30, 2026, will advance scientific understanding of how environmental PFAS exposures may...
This federal Project Grant award, valued at $546,350.00 and granted by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, supports research to define the neurotoxic and neurodevelopmental health risks of per- and polyfluoroalkyl substances (PFAS). The key products and services to be delivered include: Defining the chemical interactions that mediate neuronal uptake and accumulation of PFAS compounds. Elucidating the neurotoxic...
The federal Project Grant award of $150,000.00 was provided by the Office of Naval Research under the Basic and Applied Scientific Research program (CFDA 12.300) to Multiscale Technologies Inc. The funding supports research to advance the degradation science of per- and polyfluoroalkyl substances (PFAS) on 2-dimensional nanoconfining substrates using AI/ML-assisted methods. The research, which will be conducted from April 2025 through September 2026, aims to stimulate innovative research that...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
This federal Project Grant award of $1,226,724.00 from the Department of Defense's Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) was granted to the New Jersey Institute of Technology (NJIT) on March 31, 2025. The award will support research to develop a method for using ultrasound-generated nanobubbles to destroy per- and polyfluoroalkyl substances (PFAS) in contaminated water. The project will run through March 30, 2029. As a well-established academic...
This $1,651,801 Project Grant awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program will support research to investigate how exposure to per- and polyfluoroalkyl substances (PFAS) can impact placental health and increase susceptibility to infection-mediated preterm birth. The research, led by Wayne State University, aims to: 1) determine if PFAS exposure decreases interferon signaling and induces placental toxicity, 2)...
This $143,331 Project Grant was awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) federal grant program. The grant will fund research by Wayne State University to investigate the mechanisms by which exposure to per- and polyfluoroalkyl substances (PFAS) impacts male reproductive health. The key research activities include single-cell RNA sequencing analysis of testicular cells to understand how PFAS exposure affects...